Cerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsis

Selvaraj, Vellaisamy; Nepal, Niraj; Rogers, Steven; Manne, Nandini D. P. K.; Arvapalli, Ravikumar; Rice, Kevin M.; Asano, Shinichi; Fankenhanel, Erin; Ma, J. Y.; Shokuhfar, Tolou; Maheshwari, Mani; Blough, Eric R.

doi:10.1016/j.dib.2015.04.023

Title: Cerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsis

Full Record
Other Related Research

Abstract

The life threatening disease of sepsis is associated with high mortality. Septic patient survivability with currently available treatments has failed to improve. The purpose of this study was to evaluate whether lipopolysaccharide (LPS) induced sepsis mortality and associated hepatic dysfunction can be prevented by cerium oxide nanoparticles (CeO2NPs) treatment in male Sprague Dawley rats. Here we provide the information about the methods processing of raw data related to our study published in Biomaterials (Selvaraj et al., Biomaterials, 2015, In press) and Data in Brief (Selvaraj et al., Data in Brief, 2015, In Press). The data present here provides confirmation of cerium oxide nanoparticle treatments ability to prevent the LPS induced sepsis associated changes in physiological, blood cell count, inflammatory protein and growth factors in vivo. In vitro assays investigation the treated of macrophages cells with different concentrations of cerium oxide nanoparticle demonstrate that concentration of cerium oxide nanoparticles below 1 mg/ml did not significantly influence cell survival as determined by the MTT assay.

Authors:: Selvaraj, Vellaisamy; Nepal, Niraj; Rogers, Steven; Manne, Nandini D. P. K.; Arvapalli, Ravikumar; Rice, Kevin M.; Asano, Shinichi; Fankenhanel, Erin; Ma, J. Y.; Shokuhfar, Tolou; Maheshwari, Mani; Blough, Eric R.

Publication Date:: Tue Sep 01 00:00:00 EDT 2015

Research Org.:: Marshall Univ., Huntington, WV (United States)

Sponsoring Org.:: USDOE Office of Science (SC)

OSTI Identifier:: 1198693

Alternate Identifier(s):: OSTI ID: 1629799

Grant/Contract Number:: PS02-09ER-01; SC0008104

Resource Type:: Published Article

Journal Name:: Data in Brief

Additional Journal Information:: Journal Name: Data in Brief Journal Volume: 4 Journal Issue: C; Journal ID: ISSN 2352-3409

Publisher:: Elsevier

Country of Publication:: United States

Language:: English

Subject:: 59 BASIC BIOLOGICAL SCIENCES; Sepsis; LPS; Sprague Dawley rat; MTT; Raw 264.7; Cerium oxide nanoparticles

Citation Formats


                    Selvaraj, Vellaisamy, Nepal, Niraj, Rogers, Steven, Manne, Nandini D. P. K., Arvapalli, Ravikumar, Rice, Kevin M., Asano, Shinichi, Fankenhanel, Erin, Ma, J. Y., Shokuhfar, Tolou, Maheshwari, Mani, and Blough, Eric R. Cerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsis.  United States: N. p., 2015. 
Web.  doi:10.1016/j.dib.2015.04.023.

Copy to clipboard


                    Selvaraj, Vellaisamy, Nepal, Niraj, Rogers, Steven, Manne, Nandini D. P. K., Arvapalli, Ravikumar, Rice, Kevin M., Asano, Shinichi, Fankenhanel, Erin, Ma, J. Y., Shokuhfar, Tolou, Maheshwari, Mani, & Blough, Eric R. Cerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsis.  United States.  https://doi.org/10.1016/j.dib.2015.04.023

Copy to clipboard


                    Selvaraj, Vellaisamy, Nepal, Niraj, Rogers, Steven, Manne, Nandini D. P. K., Arvapalli, Ravikumar, Rice, Kevin M., Asano, Shinichi, Fankenhanel, Erin, Ma, J. Y., Shokuhfar, Tolou, Maheshwari, Mani, and Blough, Eric R. Tue .  
"Cerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsis".  United States.  https://doi.org/10.1016/j.dib.2015.04.023.

Copy to clipboard


                    
@article{osti_1198693,

  title        = {Cerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsis},

  author       = {Selvaraj, Vellaisamy and Nepal, Niraj and Rogers, Steven and Manne, Nandini D. P. K. and Arvapalli, Ravikumar and Rice, Kevin M. and Asano, Shinichi and Fankenhanel, Erin and Ma, J. Y. and Shokuhfar, Tolou and Maheshwari, Mani and Blough, Eric R.},

  abstractNote = {The life threatening disease of sepsis is associated with high mortality. Septic patient survivability with currently available treatments has failed to improve. The purpose of this study was to evaluate whether lipopolysaccharide (LPS) induced sepsis mortality and associated hepatic dysfunction can be prevented by cerium oxide nanoparticles (CeO2NPs) treatment in male Sprague Dawley rats. Here we provide the information about the methods processing of raw data related to our study published in Biomaterials (Selvaraj et al., Biomaterials, 2015, In press) and Data in Brief (Selvaraj et al., Data in Brief, 2015, In Press). The data present here provides confirmation of cerium oxide nanoparticle treatments ability to prevent the LPS induced sepsis associated changes in physiological, blood cell count, inflammatory protein and growth factors in vivo. In vitro assays investigation the treated of macrophages cells with different concentrations of cerium oxide nanoparticle demonstrate that concentration of cerium oxide nanoparticles below 1 mg/ml did not significantly influence cell survival as determined by the MTT assay.},

  doi          = {10.1016/j.dib.2015.04.023},

  journal      = {Data in Brief},

  number       = C,

  volume       = 4,

  place        = {United States},

  year         = {Tue Sep 01 00:00:00 EDT 2015},

  month        = {Tue Sep 01 00:00:00 EDT 2015}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Publisher's Version of Record
https://doi.org/10.1016/j.dib.2015.04.023

Other availability

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

Lipopolysaccharide induced MAP kinase activation in RAW 264.7 cells attenuated by cerium oxide nanoparticles

Journal Article Selvaraj, Vellaisamy ; Nepal, Niraj ; Rogers, Steven ; ... - Data in Brief

High mortality rates are associated with the life threatening disease of sepsis. Improvements in septic patient survivability have failed to materialize with currently available treatments. This article represents data regarding a study published in biomaterials (Vellaisamy et al., Biomaterials, 2015, in press). with the purpose of evaluating whether severe sepsis mortality and associated hepatic dysfunction induced by lipopolysaccharide (LPS) can be prevented by cerium oxide nanoparticles (CeO2NPs) treatment in male Sprague Dawley rats. Here we provide the information about the method and processing of raw data related to our study publish in Biomaterials and Data in Brief (Vellaisamy et al.,more »« less
https://doi.org/10.1016/j.dib.2015.04.022
Mitochondrial dynamics and protective effects of a mitochondrial division inhibitor, Mdivi-1, in lipopolysaccharide-induced brain damage

Journal Article Deng, Songyun ; Ai, Yuhang ; Gong, Hua ; ... - Biochemical and Biophysical Research Communications

Highlights: • Mdivi-1 ameliorated brain damage in a lipopolysaccharide-induced sepsis model. • Drp1 was up-regulated, while p-Drp1 and OPA1 were down-regulated in hippocampus. • The protective effect of Mdivi-1 could be associated with its inhibition of Drp1 and its activation of p-Drp1 and OPA1. Sepsis is one of the most common reasons for mortality in Intensive Care Units. As a common but severe neurological complication, sepsis associated encephalopathy (SAE) has always been ignored and there is no generally accepted treatment. In this study, we demonstrated that Mdivi-1 ameliorated brain damage assessed by Nissl staining. Furthermore, Mdivi-1 reduced TUNEL-positive cells inmore »« less
https://doi.org/10.1016/J.BBRC.2018.01.136
Inhibition of NLRP9b attenuates acute lung injury through suppressing inflammation, apoptosis and oxidative stress in murine and cell models

Journal Article Yanling, Qiu ; Xiaoning, Cheng ; Fei, Bai ; ... - Biochemical and Biophysical Research Communications

Highlights: • NLRP9b-deficiency suppresses inflammation and apoptosis in CLP-induced ALI in mice. • NLRP9b-knockout reduces the generation of pro-inflammatory cytokines in ALI mice. • Inhibition of NLRP9b suppresses inflammation and apoptosis by reducing ROS generation in LPS-stimulated MLE-12 cells. Acute lung injury (ALI), known a severe disease along with high morbidity and mortality, is lacking of specific therapies. Inflammation, apoptosis and oxidative stress are critical pathologies that contribute to ALI. Recently, there is study indicated that NLRP9b, a NOD-like receptor (NLR) member, is critical in modulation of inflammatory response. However, the effects of NLRP9b on sepsis-associated ALI, and the underlyingmore »« less
https://doi.org/10.1016/J.BBRC.2018.04.079
MiR-150 predicts survival in patients with sepsis and inhibits LPS-induced inflammatory factors and apoptosis by targeting NF-κB1 in human umbilical vein endothelial cells

Journal Article Ma, Yuezhen ; Liu, Yanni ; Hou, Huihui ; ... - Biochemical and Biophysical Research Communications

Highlights: • Plasma miR-150 level is reduced in patients with sepsis. • Plasma miR-150 has a diagnostic and prognostic value in septic patients. • MiR-150 protects HUVECs from LPS-induced inflammatory injury. • NF-κB1 is a direct target of miR-150. MiR-150 is involved into some pathological processes, such as tumorigenesis and autoimmune diseases. However, little is known about the involvement of miR-150 in human sepsis. In this study, plasma miR-150 level had a diagnostic and independent prognostic value in patients with sepsis, and negatively correlated with renal dysfunction and 28-day survival as well as plasma levels of interleukin-6 (IL-6) and tumormore »« less
https://doi.org/10.1016/J.BBRC.2018.04.168
Cerium oxide nanoparticles attenuate acute kidney injury induced by intra-abdominal infection in Sprague–Dawley rats

Journal Article Manne, Nandini D. P. K. ; Arvapalli, Ravikumar ; Nepal, Niraj ; ... - Journal of Nanobiotechnology

Background: Intra-abdominal infection or peritonitis is a cause for great concern due to high mortality rates. The prognosis of severe intra-abdominal infection is significantly diminished in the presence of acute kidney injury (AKI) which is often characterized by renal tubular cell death that can lead to renal failure. The purpose of the current study is to examine the therapeutic efficacy of cerium oxide (CeO2) nanoparticles for the treatment of peritonitis-induced AKI by polymicrobial insult. Results: A one-time administration of CeO2 nanoparticles (0.5 mg/kg) in the absence of antibiotics or other supportive care, attenuated peritonitis-induced tubular dilatation and the loss ofmore »« less
Cited by 42
https://doi.org/10.1186/s12951-015-0135-z

Similar Records